1. Home
  2. MDXH vs BTCS Comparison

MDXH vs BTCS Comparison

Compare MDXH & BTCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • BTCS
  • Stock Information
  • Founded
  • MDXH 2003
  • BTCS 2008
  • Country
  • MDXH Belgium
  • BTCS United States
  • Employees
  • MDXH N/A
  • BTCS N/A
  • Industry
  • MDXH
  • BTCS Finance: Consumer Services
  • Sector
  • MDXH
  • BTCS Finance
  • Exchange
  • MDXH Nasdaq
  • BTCS Nasdaq
  • Market Cap
  • MDXH 84.6M
  • BTCS 47.7M
  • IPO Year
  • MDXH 2021
  • BTCS N/A
  • Fundamental
  • Price
  • MDXH $2.18
  • BTCS $2.33
  • Analyst Decision
  • MDXH Buy
  • BTCS Strong Buy
  • Analyst Count
  • MDXH 1
  • BTCS 1
  • Target Price
  • MDXH $6.00
  • BTCS $5.00
  • AVG Volume (30 Days)
  • MDXH 67.5K
  • BTCS 608.9K
  • Earning Date
  • MDXH 08-20-2025
  • BTCS 08-18-2025
  • Dividend Yield
  • MDXH N/A
  • BTCS N/A
  • EPS Growth
  • MDXH N/A
  • BTCS N/A
  • EPS
  • MDXH N/A
  • BTCS N/A
  • Revenue
  • MDXH $94,507,000.00
  • BTCS $5,311,067.00
  • Revenue This Year
  • MDXH $23.51
  • BTCS $75.28
  • Revenue Next Year
  • MDXH $17.68
  • BTCS N/A
  • P/E Ratio
  • MDXH N/A
  • BTCS N/A
  • Revenue Growth
  • MDXH 25.46
  • BTCS 258.98
  • 52 Week Low
  • MDXH $1.35
  • BTCS $0.95
  • 52 Week High
  • MDXH $3.50
  • BTCS $5.41
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 58.07
  • BTCS 49.74
  • Support Level
  • MDXH $2.13
  • BTCS $2.09
  • Resistance Level
  • MDXH $2.32
  • BTCS $2.33
  • Average True Range (ATR)
  • MDXH 0.12
  • BTCS 0.16
  • MACD
  • MDXH 0.01
  • BTCS -0.03
  • Stochastic Oscillator
  • MDXH 76.19
  • BTCS 49.09

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About BTCS BTCS Inc.

BTCS Inc is engaged in the business of hosting an online e-commerce marketplace where consumers can purchase merchandise using Digital Assets, including bitcoin. The company focuses on blockchain and Digital Asset ecosystems. The firm operates a beta e-commerce marketplace, which accepts a range of digital currencies, has designed a beta secure digital currency storage solution BTCS Wallet. The Company's blockchain infrastructure operations include two primary revenue-generating activities: Ethereum block building and validator node operations.

Share on Social Networks: